Skip to main content
Erschienen in: Obesity Surgery 7/2013

01.07.2013 | Original Contributions

Sagittal Abdominal Diameter and Visceral Adiposity

Correlates of Beta-Cell Function and Dysglycemia in Severely Obese Women

verfasst von: Nana Gletsu-Miller, Henry S. Kahn, Danijela Gasevic, Zhe Liang, Jennifer K. Frediani, William E. Torres, Thomas R. Ziegler, Lawrence S. Phillips, Edward Lin

Erschienen in: Obesity Surgery | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

In the context of increasing obesity prevalence, the relationship between large visceral adipose tissue (VAT) volumes and type 2 diabetes mellitus (T2DM) is unclear. In a clinical sample of severely obese women (mean body mass index [BMI], 46 kg/m2) with fasting normoglycemia (n = 40) or dysglycemia (impaired fasting glucose + diabetes; n = 20), we sought to determine the usefulness of anthropometric correlates of VAT and associations with dysglycemia.

Methods

VAT volume was estimated using multi-slice computer tomography; anthropometric surrogates included sagittal abdominal diameter (SAD), waist circumference (WC) and BMI. Insulin sensitivity (Si), and beta-cell dysfunction, measured by insulin secretion (AIRg) and the disposition index (DI), were determined by frequently sampled intravenous glucose tolerance test.

Results

Compared to fasting normoglycemic women, individuals with dysglycemia had greater VAT (P < 0.001) and SAD (P = 0.04), but BMI, total adiposity and Si were similar. VAT was inversely associated with AIRg and DI after controlling for ancestry, Si, and total adiposity (standardized beta, −0.32 and −0.34, both P < 0.05). In addition, SAD (beta = 0.41, P = 0.02) was found to be a better estimate of VAT volume than WC (beta = 0.32, P = 0.08) after controlling for covariates. Receiver operating characteristic analysis showed that VAT volume, followed by SAD, outperformed WC and BMI in identifying dysglycemic participants.

Conclusions

Increasing VAT is associated with beta-cell dysfunction and dysglycemia in very obese women. In the presence of severe obesity, SAD is a simple surrogate of VAT, and an indicator of glucose dysregulation.
Literatur
1.
Zurück zum Zitat Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–41.PubMedCrossRef Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–41.PubMedCrossRef
2.
Zurück zum Zitat Knowler WC, Pettit DJ, Savage PJ, et al. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol. 1981;11:144–56. Knowler WC, Pettit DJ, Savage PJ, et al. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol. 1981;11:144–56.
3.
Zurück zum Zitat Gregg EW, Cheng YJ, Narayan KMV, et al. The relative contribution of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med. 2007;45:348–52.PubMedCrossRef Gregg EW, Cheng YJ, Narayan KMV, et al. The relative contribution of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med. 2007;45:348–52.PubMedCrossRef
4.
Zurück zum Zitat Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555–63.PubMed Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555–63.PubMed
5.
Zurück zum Zitat Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308:1150–9.PubMedCrossRef Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308:1150–9.PubMedCrossRef
6.
Zurück zum Zitat Wagenknecht LE, Langefeld CD, Scherzinger AL, et al. Insulin sensitivity, insulin secretion, and abdominal fat. The insulin resistance atherosclerois study (IRAS) Family Study. Diabetes. 2003;52:2490–6.PubMedCrossRef Wagenknecht LE, Langefeld CD, Scherzinger AL, et al. Insulin sensitivity, insulin secretion, and abdominal fat. The insulin resistance atherosclerois study (IRAS) Family Study. Diabetes. 2003;52:2490–6.PubMedCrossRef
7.
Zurück zum Zitat Utzschneider KM, Carr DB, Hull RL, et al. Impact of intraabdominal fat and age on insulin sensitivity and β-cell function. Diabetes. 2004;53:2867–72.PubMedCrossRef Utzschneider KM, Carr DB, Hull RL, et al. Impact of intraabdominal fat and age on insulin sensitivity and β-cell function. Diabetes. 2004;53:2867–72.PubMedCrossRef
8.
Zurück zum Zitat Goodplaster BH, Kelley DE, Wing RR, et al. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes. 1999;48:839–47.CrossRef Goodplaster BH, Kelley DE, Wing RR, et al. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes. 1999;48:839–47.CrossRef
9.
Zurück zum Zitat Hanley AJG, Wagenknecht L, Norris JM, et al. Insulin resistance, beta-cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Familiy Study. Diabetologia. 2009;52:2079–86.PubMedCrossRef Hanley AJG, Wagenknecht L, Norris JM, et al. Insulin resistance, beta-cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Familiy Study. Diabetologia. 2009;52:2079–86.PubMedCrossRef
10.
Zurück zum Zitat Pajunen P, Rissanen H, Laaksonen MA, et al. Sagittal abdominal diameter as a new predictor for incident diabetes. Diabetes Care. 2013;36:283–88. Pajunen P, Rissanen H, Laaksonen MA, et al. Sagittal abdominal diameter as a new predictor for incident diabetes. Diabetes Care. 2013;36:283–88.
11.
Zurück zum Zitat Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663–72.PubMedCrossRef Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663–72.PubMedCrossRef
12.
Zurück zum Zitat Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin compartments: distinct metabolic effects of two fat compartments. Diabetes. 2002;51:1005–15.PubMedCrossRef Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin compartments: distinct metabolic effects of two fat compartments. Diabetes. 2002;51:1005–15.PubMedCrossRef
13.
Zurück zum Zitat Lin E, Phillips LS, Ziegler TR, et al. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes. 2007;56:735–42.PubMedCrossRef Lin E, Phillips LS, Ziegler TR, et al. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes. 2007;56:735–42.PubMedCrossRef
14.
Zurück zum Zitat Le K-A, Ventura EE, Fisher JQ, et al. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care. 2011;34:485–90.PubMedCrossRef Le K-A, Ventura EE, Fisher JQ, et al. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care. 2011;34:485–90.PubMedCrossRef
15.
Zurück zum Zitat Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev. 2010;26:200–5.PubMedCrossRef Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev. 2010;26:200–5.PubMedCrossRef
16.
Zurück zum Zitat Kamel EG, McNeill G, Van Wijk MCW. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res. 2000;8:36–42.PubMedCrossRef Kamel EG, McNeill G, Van Wijk MCW. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res. 2000;8:36–42.PubMedCrossRef
17.
Zurück zum Zitat Zamboni M, Turcato E, Armellini F, et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes. 1998;22:655–60.CrossRef Zamboni M, Turcato E, Armellini F, et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes. 1998;22:655–60.CrossRef
18.
Zurück zum Zitat Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.PubMedCrossRef
19.
Zurück zum Zitat Lemieux S, Prud'homme D, Tremblay A, et al. Anthropometric correlates to changes in visceral adipose tissue over 7 years in women. Int J Obes. 1996;20:618–24. Lemieux S, Prud'homme D, Tremblay A, et al. Anthropometric correlates to changes in visceral adipose tissue over 7 years in women. Int J Obes. 1996;20:618–24.
20.
Zurück zum Zitat Kamel EG, McNeill G, Van Wijk MCW. Change in intra-abdominal adipose tissue volume during weight loss in obese men and women: correlation between magnetic resonance imaging and anthropometric measurements. Int J Obes. 2000;24:607–13.CrossRef Kamel EG, McNeill G, Van Wijk MCW. Change in intra-abdominal adipose tissue volume during weight loss in obese men and women: correlation between magnetic resonance imaging and anthropometric measurements. Int J Obes. 2000;24:607–13.CrossRef
21.
Zurück zum Zitat Drapeau V, Lemieux I, Richard D, et al. Waist circumference is useless to assess the prevalence on metabolic abnormalities in severely obese women. Obes Surg. 2007;17:905–9.PubMedCrossRef Drapeau V, Lemieux I, Richard D, et al. Waist circumference is useless to assess the prevalence on metabolic abnormalities in severely obese women. Obes Surg. 2007;17:905–9.PubMedCrossRef
22.
Zurück zum Zitat American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30:S42–7.CrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30:S42–7.CrossRef
23.
Zurück zum Zitat Bergman RN. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989;38:1512–27.PubMedCrossRef Bergman RN. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989;38:1512–27.PubMedCrossRef
24.
Zurück zum Zitat Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African Americans, Non-Hispanic Whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes. 1997;46:63–9.PubMedCrossRef Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African Americans, Non-Hispanic Whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes. 1997;46:63–9.PubMedCrossRef
25.
Zurück zum Zitat Garcia-Fuentes E, Garcia-Almeida JM, Garcia-Arnes J, et al. Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes Surg. 2006;16:1179–88.PubMedCrossRef Garcia-Fuentes E, Garcia-Almeida JM, Garcia-Arnes J, et al. Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes Surg. 2006;16:1179–88.PubMedCrossRef
26.
Zurück zum Zitat Lin E, Liang Z, Frediani J, et al. Improvement in beta-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab. 2010;299:E706–12.PubMedCrossRef Lin E, Liang Z, Frediani J, et al. Improvement in beta-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab. 2010;299:E706–12.PubMedCrossRef
27.
Zurück zum Zitat Gan SK, Kriketos AD, Poynten AM, et al. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res. 2003;11:1295–305.PubMedCrossRef Gan SK, Kriketos AD, Poynten AM, et al. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res. 2003;11:1295–305.PubMedCrossRef
28.
Zurück zum Zitat Gastaldelli A, Sironi AM, Ciociaro D, et al. Visceral fat and beta-cell function in non-diabetic humans. Diabetologia. 2005;48:2090–6.PubMedCrossRef Gastaldelli A, Sironi AM, Ciociaro D, et al. Visceral fat and beta-cell function in non-diabetic humans. Diabetologia. 2005;48:2090–6.PubMedCrossRef
29.
Zurück zum Zitat Macor C, Ruggeri A, Mazzenetto P, et al. Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity. Metab Clin Exp. 1997;46:123–9.PubMedCrossRef Macor C, Ruggeri A, Mazzenetto P, et al. Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity. Metab Clin Exp. 1997;46:123–9.PubMedCrossRef
30.
Zurück zum Zitat Goran MI, Lane C, Toledo-Corral C, et al. Persistence of pre-diabetes in overweight and obese Hispanic children. Association with progressive insulin resistance, poor B-cell function, and increasing visceral fat. Diabetes. 2008;57:3007–12.PubMedCrossRef Goran MI, Lane C, Toledo-Corral C, et al. Persistence of pre-diabetes in overweight and obese Hispanic children. Association with progressive insulin resistance, poor B-cell function, and increasing visceral fat. Diabetes. 2008;57:3007–12.PubMedCrossRef
31.
Zurück zum Zitat Maedler K, Oberholzer J, Bucher P, et al. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003;52:726–33.PubMedCrossRef Maedler K, Oberholzer J, Bucher P, et al. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003;52:726–33.PubMedCrossRef
32.
Zurück zum Zitat Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704.PubMedCrossRef Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704.PubMedCrossRef
33.
Zurück zum Zitat Nordhamn K, Sodergren E, Olsson E, et al. Reliability of antropometric measurements in overweight and lean subjects: consequences for correlations between anthropometrics and other variables. Int J Obes. 2000;24:652–7.CrossRef Nordhamn K, Sodergren E, Olsson E, et al. Reliability of antropometric measurements in overweight and lean subjects: consequences for correlations between anthropometrics and other variables. Int J Obes. 2000;24:652–7.CrossRef
34.
Zurück zum Zitat Sjostrom L, Lonn L, Chowdhury B, et al. The sagittal diameter is a valid marker of the visceral adipose tissue volume. In: Angel A, Anderson H, Bouchard B, Lau D, Leiter L, Mendelson R, editors. Progress in obesity research. Herts, United Kingdom: John Libbey & Company Ltd.; 1996. pp. 309–19. Sjostrom L, Lonn L, Chowdhury B, et al. The sagittal diameter is a valid marker of the visceral adipose tissue volume. In: Angel A, Anderson H, Bouchard B, Lau D, Leiter L, Mendelson R, editors. Progress in obesity research. Herts, United Kingdom: John Libbey & Company Ltd.; 1996. pp. 309–19.
35.
Zurück zum Zitat Sampaio LR, Simoes EJ, Assis AMO, et al. Validity and reliability of the sagittal abdominal diameter as a predictor of visceral abdominal fat. Arq Bras Endocrinol Metab. 2007;51:980–6.CrossRef Sampaio LR, Simoes EJ, Assis AMO, et al. Validity and reliability of the sagittal abdominal diameter as a predictor of visceral abdominal fat. Arq Bras Endocrinol Metab. 2007;51:980–6.CrossRef
36.
Zurück zum Zitat Yim JY, Kim D, Lim SH, et al. Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care. 2010;33:2665–70.PubMedCrossRef Yim JY, Kim D, Lim SH, et al. Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care. 2010;33:2665–70.PubMedCrossRef
37.
Zurück zum Zitat Salmenniemi U, Ruotsalainen E, Vanttinen M, et al. High amount of visceral fat mass is associated with multiple metabolic changes in offspring of type 2 diabetic patients. Int J Obes. 2005;29:1464–70.CrossRef Salmenniemi U, Ruotsalainen E, Vanttinen M, et al. High amount of visceral fat mass is associated with multiple metabolic changes in offspring of type 2 diabetic patients. Int J Obes. 2005;29:1464–70.CrossRef
38.
Zurück zum Zitat Nakata K, Choo J, Hopson MJS, et al. Stronger associations of sagittal abdominal diameter with atherogenic lipoprotein subfractions than waist circumference in middle-aged US white and Japanese men. Metab Clin Exp. 2010;59:1742–51.PubMedCrossRef Nakata K, Choo J, Hopson MJS, et al. Stronger associations of sagittal abdominal diameter with atherogenic lipoprotein subfractions than waist circumference in middle-aged US white and Japanese men. Metab Clin Exp. 2010;59:1742–51.PubMedCrossRef
39.
Zurück zum Zitat Riserus U, Arnlov J, Brismar K, et al. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care. 2004;27:2041–6.PubMedCrossRef Riserus U, Arnlov J, Brismar K, et al. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care. 2004;27:2041–6.PubMedCrossRef
40.
Zurück zum Zitat Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care. 2010;33:562–8.PubMedCrossRef Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care. 2010;33:562–8.PubMedCrossRef
41.
Zurück zum Zitat Muniyappa R, Lee S, Chen H, et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15–26.PubMedCrossRef Muniyappa R, Lee S, Chen H, et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15–26.PubMedCrossRef
42.
Zurück zum Zitat Sjostrom L. A computer-tomography based multicomponent body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. Int J Obes. 1991;1991:19–30. Sjostrom L. A computer-tomography based multicomponent body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. Int J Obes. 1991;1991:19–30.
Metadaten
Titel
Sagittal Abdominal Diameter and Visceral Adiposity
Correlates of Beta-Cell Function and Dysglycemia in Severely Obese Women
verfasst von
Nana Gletsu-Miller
Henry S. Kahn
Danijela Gasevic
Zhe Liang
Jennifer K. Frediani
William E. Torres
Thomas R. Ziegler
Lawrence S. Phillips
Edward Lin
Publikationsdatum
01.07.2013
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 7/2013
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-013-0874-6

Weitere Artikel der Ausgabe 7/2013

Obesity Surgery 7/2013 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.